Kukis, D L <br/><br/>
Cleavable linkers to enhance selectivity of antibody-targeted therapy of cancer.  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Dec 2001 
 - 457-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1084-9785 
<br/><br/><label>Standard No.: </label>10.1089/10849780152752065  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cross-Linking Reagents<br/>Humans<br/>Immunoconjugates--chemistry<br/>Kidney--metabolism<br/>Liver--metabolism<br/>Metabolic Clearance Rate<br/>Neoplasms--therapy<br/>Radioimmunotherapy<br/>Radiopharmaceuticals--chemistry